Maher, Pamela <br/><br/>
ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease.  [electronic resource] 

 -  Human molecular genetics  Jan 2011 
 - 261-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1460-2083 
<br/><br/><label>Standard No.: </label>10.1093/hmg/ddq460  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Disease Models, Animal<br/>Drosophila--drug effects<br/>Enzyme Activation--drug effects<br/>Extracellular Signal-Regulated MAP Kinases--genetics<br/>Flavonoids--pharmacology<br/>Flavonols<br/>Gene Dosage--drug effects<br/>Gene Expression Regulation--drug effects<br/>Huntingtin Protein<br/>Huntington Disease--enzymology<br/>JNK Mitogen-Activated Protein Kinases--genetics<br/>Mice<br/>Motor Activity--drug effects<br/>Nerve Tissue Proteins--genetics<br/>Neuroprotective Agents--pharmacology<br/>Nuclear Proteins--genetics<br/>PC12 Cells<br/>Rats<br/>Resveratrol<br/>Stilbenes--pharmacology<br/>Survival Analysis